HIGHLIGHTS
- who: Arezoo Mohammadi et al. from the Student Research Committee, Health Research Center, Babol University of Medical Sciences, Babol, Iran have published the paper: Galangin Nanoparticles Protect Acetaminophen-Induced Liver Injury: A Biochemical and Histopathological Approach, in the Journal: Evidence-Based Complementary and Alternative Medicine of 10/08/2022
- what: This study was conducted to investigate the possible role of galangin in reducing acetaminophen-induced hepatotoxicity. The results of this study showed that PCO levels in the acetaminophen group with an oral dose of 2 g/kg Groups 1 2 3 4 5 6 Hyperemia . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.